Advertisement

Chinese Journal of Integrative Medicine

, Volume 24, Issue 3, pp 218–226 | Cite as

Conventional Acupuncture for Cardiac Arrhythmia: A Systematic Review of Randomized Controlled Trials

  • Jing Liu
  • Si-nai Li
  • Lu Liu
  • Kun Zhou
  • Yan Li
  • Xiao-yun Cui
  • Jie Wan
  • Jin-jin Lu
  • Yan-chao Huang
  • Xu-sheng Wang
  • Qian Lin
Evidence-Based Integrative Medicine

Abstract

Objective

To exam the effect and safety of conventional acupuncture (CA) on cardiac arrhythmia.

Methods

Nine medical databases were searched until February 2016 for randomized controlled trials. Heterogeneity was measured by Cochran Q test. Meta-analysis was conducted if I2 was less than 85% and the characteristics of included trials were similar.

Results

Nine qualified studies involving 638 patients were included. Only 1 study had definitely low risk of bias, while 7 trials were rated as unclear and 1 as high. Meta-analysis of CA alone did not have a significant benefit on response rate compared to amiodarone in patients with atrial fibrillation (Af) and atrial flutter (AF) [relative risk (RR): 1.09; 95% confidence interval (CI): 0.79–1.49; P=0.61; I2=61%, P=0.11]. However, 1 study with higher methodological quality detected a lower recurrence rate of Af in CA alone as compared with sham acupuncture plus no treatment, and benefits on ventricular rate and time of conversion to normal sinus rhythm were found in CA alone group by 1 study, as well as the response rate in CA plus deslanoside group by another study. Meta-analysis of CA plus anti-arrhythmia drug (AAD) was associated with a significant benefit on the response rate when compared with AAD alone in ventricular premature beat (VPB) patients (RR, 1.19, 95% CI: 1.05–1.34; P=0.005; I2=13%, P=0.32), and an improvement in quality-of-life score (QOLS) of VPB also showed in 1 individual study. Besides, a lower heart rate was detected in the CA alone group by 1 individual study when compared with no treatment in sinus tachycardia patients (MD–21.84 [–27.21,–16.47]) and lower adverse events of CA alone were reported than amiodarone.

Conclusions

CA may be a useful and safe alternative or additive approach to AADs for cardiac arrhythmia, especially in VPB and Af patients, which mainly based on a pooled estimate and result from 1 study with higher methodological quality. However, we could not reach a robust conclusion due to low quality of overall evidence.

Keywords

acupuncture cardiac arrhythmia systematic review 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

11655_2017_2753_MOESM1_ESM.pdf (276 kb)
Supplementary material, approximately 277 KB.

References

  1. 1.
    Types of Arrhythmia. Available at: http://www.nhlbi.nih.gov. July 1, 2011. Retrieved 8 November 2016.Google Scholar
  2. 2.
    Martin C, Matthews G, Huang CL. Sudden cardiac death and Inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease. Heart 2012;8:536–543.CrossRefGoogle Scholar
  3. 3.
    Silvia GP, Carina BL, Andrea M, Nico B, Martin B, John C, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J 2015;36:2793–2867.CrossRefGoogle Scholar
  4. 4.
    Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias). Circulation 2003;108:1871–1909.CrossRefPubMedGoogle Scholar
  5. 5.
    January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2014;64:e1–e76.CrossRefPubMedGoogle Scholar
  6. 6.
    The Cardiac Arrhythmia Suppression Trial (CAT) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAT) Investigators. N Engl J Med 1989;321:406–412.CrossRefGoogle Scholar
  7. 7.
    Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, et al. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667–674.CrossRefPubMedGoogle Scholar
  8. 8.
    Saksena S, Slee A, Waldo AL, Freemantle N, Reynolds M, Rosenberg Y, et al. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): an assessment of individual antiarrhythmia drug therapies compared with rate control with propensity score-matched analyses. J Am Coll Cardiol 2011;58:1975–1985.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Waldo AL, Camm AJ, de Ruyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of D-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, et al. PALLAS Investigators (2011) Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2012;365:2268–2276.CrossRefGoogle Scholar
  11. 11.
    Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebocontrolled trial. Lancet 2008;372:807–816.CrossRefPubMedGoogle Scholar
  12. 12.
    Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segmentelevation acute coronary syndrome: results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2007;116:1647–1652.CrossRefPubMedGoogle Scholar
  13. 13.
    Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. Multi-Center Study of Perioperative Ischemia Research Group. JAMA 1996;276:300–306.Google Scholar
  14. 14.
    Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WC. Cost effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol 2002;40:737–745.CrossRefPubMedGoogle Scholar
  15. 15.
    Kang XZ, Xia Y. Acupuncture therapy for arrhythmia and other cardiac disorders: clinical and laboratory investigation. Acupunct Res (Chin) 2009;34:413–420.Google Scholar
  16. 16.
    VanWormer AM, Lindquist R, Sendelbach SE. The effects of acupuncture on cardiac arrhythmias: a literature review. Heart Lung 2008;37:425–431.CrossRefPubMedGoogle Scholar
  17. 17.
    Kim TH, Choi TY, Lee MS, Ernst E. Acupuncture treatment for cardiac arrhythmias: a systematic review of randomized controlled trials. Int J Cardiol 2011;149:263–265.CrossRefPubMedGoogle Scholar
  18. 18.
    Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. BMJ 2009;339:b2535.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://handbook.cochrane.orgGoogle Scholar
  20. 20.
    Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ 2011;343:d5928.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011], Chapter 9 (section 9.3.9). The Cochrane Collaboration, 2011. Available at: http://handbook.cochrane. org.Google Scholar
  22. 22.
    Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], Chapter 16 (section 16.5.4). The Cochrane Collaboration, 2011. Available at: http://handbook.cochrane. org.Google Scholar
  23. 23.
    Liu LY, Li ZP. Observation on the clinical curative effect of propafenone with acupuncturing Neiguan on frequent ventricular premature beat. Chin J Integr Tradit West Med Intens Crit Care (Chin) 1999;6:65–66.Google Scholar
  24. 24.
    Li H. The transient effect of acupoint selection of Linggui Bafa on sinus tachycardia. Chin Acupunct Moxibust (Chin) 2003;23:132–134.Google Scholar
  25. 25.
    Dong SJ. 32 caes of paroxysmal supraventricular tachycardia in acupuncture Neiguan. J Henan Univ Tradit Chin Med (Chin) 2006;21:69–70.Google Scholar
  26. 26.
    Xu HK, Zhang YF. Comparison between therapeutic effects of acupuncture and intravenous injection of amiodarone in the treatment of paroxysmal atrial fibrillation and atrial flutter. Chin J Acupunct Moxibust (Chin) 2007;27:96–98.Google Scholar
  27. 27.
    Zhong CH. Observations on the efficacy of combined acupuncture and medicine in treating ventricular premature beat without organic heart disease. Shanghai J Acupunct Moxibust (Chin) 2008;27:15–16.Google Scholar
  28. 28.
    Wang F, Zhou L, Xia LM, Jiang XP. Clinical observations on acupuncture point injection plus medication for the treatment of coronary heart disease-caused ventricular premature beats. Shanghai J Acupunct Moxibust (Chin) 2012;31:96–97.Google Scholar
  29. 29.
    Han BD. Clinical observation on 62 caes of paroxysmal rapid atrial fibrillation treated by acupuncture combined with drug therapy. J Emerg Tradit Chin Med (Chin) 2012;21:303.Google Scholar
  30. 30.
    Chen L, Chen ZHF, Yang XX, Jiang W, Zhou WB, Yin KCH. The efficacy and safety of Neiguan acupoint catgut embedding therapy for atrial fibrillation. J New Chin Med (Chin) 2012;44:148–150.Google Scholar
  31. 31.
    Alberto L, Sebastiano B, Maria BP, Federico L. Efficacy of acupuncture in preventing atrial fibrillation recurrence after electrical cardioversion. J Cardiovasc Electrophysiol 2011;22:241–247.CrossRefGoogle Scholar
  32. 32.
    Guo XZH, ed. Basic theory of traditional Chinese medicine. Shanghai: Shanghai Scientific and Technical Publishers; 2006.Google Scholar
  33. 33.
    Shen XY, ed. Meridians and acupoints. Beijing: China Press of Traditional Chinese Medicine; 2003.Google Scholar
  34. 34.
    Yang J, ed. Acupuncture and moxibustion therapeutics. Beijing: China Science Publisher; 2004.Google Scholar
  35. 35.
    Du HJ, Chen F, Tang GM, Xu WB. The influence of electroacupuncturing Neiguan and Xinshu on MMP-2, TIMP-2 of myocardial tissue in acute myocardial infarction rat model. J Shanxi Univ Tradit Chin Med (Chin) 2015;16:22–24.Google Scholar
  36. 36.
    Xiao YL, Du YH, Shi XM. The effect of acupuncturing Neiguan point on ET and NO in myocardial ischemic of AMI model rats. Chin J Clin Rehabil (Chin) 2002;6:1582–1583.Google Scholar
  37. 37.
    Wu S, Li J, Hong YQ, Liang FX, Tang HT, Liu JM, et al. The influence of electro-acupuncturing Neiguan on p38MAPK signaling pathway in rats with cardiac hypertrophy. Chin Acupunct Moxibust (Chin) 2012;32:145–148.Google Scholar
  38. 38.
    Li XL. Clinical study on regulation of acupuncture on plasma TXB2 and 6-Keto-PGF1a in the patient of angina pectoris due to coronary heart disease. Chin Acupunct Moxibust (Chin) 1999;19:227–229.Google Scholar
  39. 39.
    Huang EM, Wu XP, Wang YW, Liu YX, Hu P, Yan SHX. The influence of electro-acupuncturing Neiguan on transmembrane potential of myocytes in acute myocardial infarction rabbit mode. J Acupunct Res (Chin) 1995;20:33–35.Google Scholar
  40. 40.
    Liu N. The influence of electro-acupuncturing Neiguan on cAMP-PKA signaling pathway in tachyarrhythmia rat model [dissertation]. Shenyang: Liaoning Univ Tradi Chin Med; 2009.Google Scholar
  41. 41.
    Qin LP, Gao JH, Fu WX, Lu B, Cui HF, Wang YM, et al. The mechanism of acupuncture preconditioning in improving ischemic arrhythmia-inhibition of intracellular calcium oscillations in cardiac myocytes. J Acupunct Res (Chin) 2008;33:75–79.Google Scholar
  42. 42.
    Guo XF, Lai SL, Liang WX, Wen ZH, Wang Q, Lao YR, et al. Selection and application of outcome index in evaluation of clinical efficacy of traditional Chinese medicine. J Guangzhou Univ Tradit Chin Med (Chin) 2002;19:251–255.Google Scholar
  43. 43.
    Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007;146:878–881.CrossRefPubMedGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine 2017

Authors and Affiliations

  • Jing Liu
    • 1
    • 2
  • Si-nai Li
    • 3
  • Lu Liu
    • 1
    • 2
  • Kun Zhou
    • 4
  • Yan Li
    • 1
    • 2
  • Xiao-yun Cui
    • 1
    • 2
  • Jie Wan
    • 5
  • Jin-jin Lu
    • 1
    • 2
  • Yan-chao Huang
    • 1
    • 2
  • Xu-sheng Wang
    • 5
  • Qian Lin
    • 1
    • 2
  1. 1.Beijing University of Chinese MedicineBeijingChina
  2. 2.Department of Cardiology, Dongfang HospitalBeijing University of Chinese MedicineBeijingChina
  3. 3.Beijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese MedicineCapital Medical UniversityBeijingChina
  4. 4.Scientific Research Division, Dongfang HospitalBeijing University of Chinese MedicineBeijingChina
  5. 5.Intensive Care Unit, Dongfang HospitalBeijing University of Chinese MedicineBeijingChina

Personalised recommendations